July 22nd, 2012
The fight against HIV has been part of my life’s work and one of my greatest passions. I first met this enemy as a young physician in training in Africa in the early 1980s. Today, as Worldwide Chairman of the Pharmaceuticals Group of Johnson & Johnson, I am privileged to be part of a company whose purpose is caring for people.
This purpose inspires me and other employees of Johnson & Johnson as we try every day to create new solutions for patients. And, it’s what has guided our approach to fighting the devastating global epidemic of HIV/AIDS.
As we prepare for this week’s AIDS 2012 Conference, I thought about how our commitment to the doctors, nurses, patients, communities and our employees affected by HIV is the focus of everything we do. Our commitment to them is what guides our extensive research and development of medicines to treat AIDS; combat resistance; simplify treatment; discover, develop, and submit for approval a novel compound for drug-resistant TB; and conduct early basic research toward fulfilling the dream of an AIDS vaccine.
It’s also what inspires us to partner with more than 100 community-based organizations in 40 countries and to contribute to the UN Millennium Development Goals to reduce mortality in women and children by 2015.